What is STILLMEADOW?
STILLMEADOW, Inc. operates as an independent Good Laboratory Practice (GLP) Contract Research Organization (CRO) with over five decades of expertise in environmental toxicology, animal health, and analytical services. The company caters to a broad spectrum of clients across the agriculture, veterinary, pharmaceutical, and chemical industries, ensuring adherence to stringent regulatory standards such as EPA and OECD guidelines. STILLMEADOW's comprehensive service portfolio includes critical support for drug development, detailed toxicology testing, and specialized analytical services, all customized to meet the unique requirements of its diverse clientele, which encompasses environmental consulting firms, government bodies, and industrial facilities.
How much funding has STILLMEADOW raised?
STILLMEADOW has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for STILLMEADOW?
The substantial late-stage funding indicates a strategic phase for STILLMEADOW, likely focused on expanding its service capabilities, enhancing its technological infrastructure, or broadening its market reach within the highly regulated CRO industry. This capital infusion is expected to fuel further growth and solidify its competitive advantage in providing essential testing and analytical services to its client base.
See full STILLMEADOW company page
